Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11957688 Combination therapy with apilimod and glutamatergic agents

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Sean Landrette0

Jonathan M. Rothberg0

Henri Lichenstein0

Peter Ronald Young0

Date of Patent

April 16, 2024

0

Patent Application Number

178624710

Date Filed

July 12, 2022

0

Patent Citations

US Patent 7045517 Triazine compounds

0

US Patent 7067514 Pyrimidine compounds

0

US Patent 7470681 Pyrimidine compounds

0

US Patent 7745436 Disalt inhibitors of IL-12 production

0

US Patent 7851466 Pyrimidine compounds and uses thereof

0

US Patent 7863270 IL-12 modulatory compounds

0

US Patent 7919487 Heteroaryl compounds

0

US Patent 7923557 Process for preparing trisubstituted pyrimidine compounds

0

...

Patent Primary Examiner

Raymond J. Henley, III

0

CPC Code

0

0

0

0

Patent abstract

Provided are compositions and methods related to the use of apilimod in combination with glutamatergic agents for treating neurological diseases and disorders, and for the treatment of cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11957688 Combination therapy with apilimod and glutamatergic agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool